Effective and Cheaper Treatment for Rheumatoid Arthritis

advertisement

Main Digest

Rheumatoid arthritis (RA) is a chronic auto-immune disease that causes pain and stiffness in the joints, fatigue, bone damage and, eventually, loss of mobility. RA afflicts around 1% of people in the western world; in Belgium, 80,000 to 100,000 people currently live with the disease.

Because there is no known cure for RA, physicians focus treatment on suppressing disease activity. Therapies have improved in recent years, and clinical studies show that intensive treatment of early RA can prevent joint damage and improve patients' quality of life.

In the two-year study, called 'CareRA' (Care in early RA), researchers and clinicians in the rheumatology unit at University Hospitals Leuven examined various therapies for early RA.

The Goal

To find the optimal combination and dosage of three commonly prescribed antirheumatic drugs (methotrexate, sulfasalazine and leflunomide) in combination with glucocorticoids (a class of steroid hormones).

The researchers divided 290 early RA patients into three treatment groups. Each group received a different combination therapy:

• 'COBRA Classic' (methotrexate, sulfasalazine and a high first dose of glucocorticoids),
• 'COBRA Slim' (methotrexate and a moderate dose of glucocorticoids)
• or 'COBRA Avant-Garde' (methotrexate, leflunomide and a moderate dose of glucocorticoids).

Fewer Side Effects

All three strategies showed a similarly high efficacy: disease remission was achieved in 7 in 10 patients after 16 weeks of treatment. But results for the strategies varied significantly when it came to side effects.

The new COBRA Slim strategy, which calls for the least amount of medication, had half as many side effects as the two other strategies - and was just as effective. The strategy would also be easier to implement in daily practice because it is less complicated.

A broader use of this strategy would lead to higher remission rates in the global early RA population and would probably reduce the need for expensive second-line antirheumatic treatment, say the researchers.

"One surprising finding in the study was the high remission values recorded for all of the applied intensive treatment strategies, which were unprecedented internationally," says Diederik De Cock, doctoral researcher at the Research Center for Skeletal Biology and Engineering (KU Leuven).

"Methotrexate is very affordable, as are steroids," says Diederik De Cock.

"Implementing this therapy across Flanders would mean substantial savings. At the moment, RA treatment is not yet adequately standardized in Belgium, and this leads to treatment inefficiencies. As a result, more patients require expensive second-line antirheumatic therapies known as biologicals, which can cost up to 15,000 euros per year. By comparison, the COBRA Slim strategy costs less than 1,000 euros. In other words, we can treat up to 15 patients for the same price as a year of treatment with a biological," says Diederik De Cock.

This research benefited from the support of the IWT (Agency for Innovation by Science and Technology) and the Pfizer Chair for Early Rheumatoid Arthritis Management at the KU Leuven held by Professor Patrick Verschueren. The study was conducted in partnership with various rheumatology centers in Flanders.

Attribution/Source(s):

This quality-reviewed article relating to our Rheumatoid Arthritis (RA) section was selected for publishing by the editors of Disabled World due to its likely interest to our disability community readers. Though the content may have been edited for style, clarity, or length, the article "Effective and Cheaper Treatment for Rheumatoid Arthritis" was originally written by KU Leuven, and published by Disabled-World.com on 2014/11/11 (Updated: 2021/04/03). Should you require further information or clarification, KU Leuven can be contacted at med.kuleuven.be. Disabled World makes no warranties or representations in connection therewith.

advertisement

Discover Related Topics ▶

Share This Information To:
𝕏.com Facebook Reddit

Disabled World provides general information only. Materials presented are never meant to substitute for qualified professional medical care. Any 3rd party offering or advertising does not constitute an endorsement.